RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,223,216 | -53.3% | 264,354 | -30.2% | 0.00% | – |
| Q2 2023 | $4,757,175 | -53.9% | 378,756 | -39.5% | 0.00% | -100.0% |
| Q1 2023 | $10,308,622 | +94.6% | 625,903 | +76.6% | 0.00% | 0.0% |
| Q4 2022 | $5,296,066 | +55.7% | 354,489 | +133.2% | 0.00% | – |
| Q3 2022 | $3,401,000 | +67.4% | 152,026 | +25.3% | 0.00% | – |
| Q2 2022 | $2,032,000 | -19.9% | 121,361 | +43.1% | 0.00% | – |
| Q1 2022 | $2,538,000 | -46.0% | 84,819 | -44.6% | 0.00% | – |
| Q4 2021 | $4,703,000 | +310.7% | 153,144 | +321.8% | 0.00% | – |
| Q3 2021 | $1,145,000 | -49.0% | 36,310 | -40.8% | 0.00% | – |
| Q2 2021 | $2,243,000 | +65.9% | 61,296 | +56.6% | 0.00% | – |
| Q1 2021 | $1,352,000 | +286.3% | 39,131 | +363.7% | 0.00% | – |
| Q4 2020 | $350,000 | +560.4% | 8,439 | +583.3% | 0.00% | – |
| Q3 2020 | $53,000 | – | 1,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |